YOLFTbeta
INVO Fertility, Inc.

INVO Fertility, Inc.

IVF · NASDAQ · Healthcare / Medical Devices

2.60USD-0.08 (-3.17%)

Price History

Full chart

Market Stats

Previous Close2.69
Open2.63
Day Range2.60 – 2.77
52-Week Range0.90 – 56.00
Volume26.26K
Market Cap2.37M
P/E (TTM)0.00
Forward P/E0.00
EPS357.88
Dividend Yield0.00%
50-Day Avg1.03
200-Day Avg2.86

About

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Steven M. Shum
  • Employees40
  • Headquarters5582 Broadcast Court, Sarasota, FL, United States, 34240, USA
  • Websitehttps://www.invofertility.com

Leadership

  • Mr. Steven M. ShumCEO & Director · b. 1971
  • Ms. Terah KrigsvoldChief Financial Officer · b. 1983
  • Mr. Andrea GorenChief Business Officer · b. 1967

Financials

Income Statement

Currency: USD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--37.99K63.20K67.65K71.50K56.38K27.06K16.59K11.69K50.90K282.14K494.38K1.48M1.04M4.16M822.20K3.02M6.53M6.84M
Growth (%)---+66.35%+7.03%+5.70%-21.15%-52.00%-38.71%-29.53%+335.46%+454.30%+75.22%+199.41%-29.92%+301.06%-80.24%+267.38%+116.25%+4.73%
Cost of Revenue-6.15K10.09K41.39K21.83K17.91K20.88K10.58K7.68K7.81K15.09K51.95K90.37K139.67K88.76K145.05K850.77K1.93M3.66M4.31M
Gross Profit--6.15K27.91K21.81K45.82K53.59K35.50K16.48K8.91K3.88K35.81K230.19K404.01K1.34M948.53K4.02M-28.57K1.09M2.87M2.53M
Gross Margin--73.45%34.51%67.73%74.95%62.96%60.89%53.69%33.19%70.35%81.59%81.72%90.56%91.44%96.51%-3.48%35.96%44.00%36.96%
Operating Expense-204.37K1.89M1.86M1.56M756.72K587.80K621.71K1.69M598.95K2.15M870.61K3.04M3.13M6.46M9.23M10.60M7.85M11.00M8.37M
Operating Income-7.60K-210.52K-1.86M-1.84M-1.52M-703.13K-552.30K-605.23K-1.68M-595.07K-2.11M-640.42K-2.63M-1.79M-5.51M-5.22M-10.63M-6.77M-8.13M-5.84M
Operating Margin---4899.22%-2915.59%-2240.10%-983.35%-979.65%-2236.39%-10131.28%-5090.89%-4146.12%-226.98%-532.81%-120.80%-531.67%-125.39%-1292.45%-224.04%-124.40%-85.36%
EBITDA-7.39K-204.37K-1.85M-1.32M323.61K-620.40K-562.03K-697.27K-1.67M-4.92M-2.11M-678.48K-2.63M-1.76M-5.48M-5.22M-10.75M-6.88M-7.14M-3.51M
EBITDA Margin---4879.46%-2090.53%478.38%-867.66%-996.92%-2576.48%-10067.79%-42104.51%-4142.43%-240.47%-531.76%-119.09%-527.94%-125.45%-1307.83%-227.77%-109.35%-51.26%
Net Income-7.39K-214.09K-1.87M-4.66M-153.43K-797.47K-666.45K-760.68K-1.73M-4.96M-2.12M-702.16K-3.08M-2.17M-8.35M-6.65M-10.89M-8.03M-9.10M-23.32M
Net Income Margin---4930.66%-7375.39%-226.81%-1115.30%-1182.14%-2810.77%-10444.13%-42426.61%-4173.30%-248.87%-622.22%-146.43%-804.73%-159.97%-1324.81%-266.00%-139.25%-340.92%
R&D-33.35K51.76K7.65K----------398.43K216.43K544.04K165.94K489.66K0
R&D as % of Total Revenue--136.23%12.10%----------38.41%5.20%66.17%5.49%7.50%0.00%
Interest Expense-3.57K11.95K3.33M463.00K155.72K92.91K51.90K51.90K32.02K13.84K20.87K442.03K379.02K2.84M1.27M59.45K925.91K1.06M1.30M
Interest Expense % of Total Revenue--31.44%5262.65%684.43%217.78%164.80%191.76%312.85%273.91%27.19%7.40%89.41%25.61%273.45%30.42%7.23%30.65%16.17%19.03%

Balance Sheet

Currency: USD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.79K55.77K761.55K442.84K181.00K127.88K125.27K122.54K108.05K579.79K286.23K266.41K777.35K1.80M10.95M10.47M3.71M18.51M46.45M20.22M
Total Liabilities250156.70K988.12K3.52M2.66M3.05M3.50M3.94M4.47M4.34M4.90M5.26M3.50M5.51M5.20M3.16M4.69M17.61M33.70M13.00M
Total Equity37.54K-100.93K-226.57K-3.08M-2.48M-2.93M-3.37M-3.81M-4.36M-3.76M-4.62M-4.99M-2.72M-3.71M5.74M7.31M-977.61K892.83K12.75M7.22M
Cash13.79K4.65K15.72K79.05K12.53K4037.19K18.03K18.63K492.00K152.40K25.76K212.24K1.24M10.10M5.68M90.14K232.42K741.40K2.08M
Total Debt-142.77K146.46K208.56K449.59K487.29K474.89K474.89K540.89K220.89K352.61K342.61K395.59K457.47K775.02K2.12M2.27M6.30M9.90M3.40M
Net Debt-13.79K142.77K130.75K129.51K437.06K486.89K467.69K456.86K522.26K-271.12K200.21K316.85K183.35K-781.12K-9.32M-3.56M2.18M6.07M9.15M1.32M

Cash Flow

Currency: USD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.01K-116.04K-1.07M-926.66K-315.99K-117.78K-43.21K-59.92K-19.40K-151.62K-323.90K-181.27K-652.97K1.37M-4.78M-6.03M-6.60M-4.76M-2.97M-7.01M
Investing Cash Flow--46.73K-73.88K--------15.70K--19.40K-114.71K-187.25K-2.15M-81.22K-2.49M363.89K-2.75M
Financing Cash Flow14.80K162.77K1.16M990.00K249.47K105.66K50.00K70.75K20.00K625.00K-54.63K858.86K-229.47K13.82M3.77M1.09M7.39M3.12M11.10M
Capital Expenditure0042.86K420000215.70K019.40K64.84K88.93K454.65K12.73K444.73K183.70K43.41K
Free Cash Flow-1.01K-116.04K-1.11M-926.66K-315.99K-117.78K-43.21K-59.92K-19.40K-151.62K-339.60K-181.27K-672.37K1.31M-4.86M-6.48M-6.62M-5.20M-3.16M-7.06M
FCF to OCF100.00%100.00%104.02%100.00%100.00%100.00%100.00%100.00%100.00%100.00%104.85%100.00%102.97%95.27%101.86%107.54%100.19%109.35%106.18%100.62%

Earnings

Report DateDec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017May 15, 2018Aug 14, 2018Nov 14, 2018Dec 31, 2018Apr 16, 2019Aug 14, 2019Nov 14, 2019Mar 30, 2020May 15, 2020Aug 13, 2020Dec 2, 2020Mar 30, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 31, 2022May 16, 2022Aug 15, 2022Nov 14, 2022Apr 17, 2023Aug 14, 2023Nov 13, 2023May 13, 2024Aug 14, 2024Nov 11, 2024Dec 31, 2024Apr 30, 2025Aug 14, 2025Nov 17, 2025Dec 31, 2025Jun 22, 2026Aug 14, 2026Nov 16, 2026
EPS Estimate--------------------------------0.00-0.25-0.19-0.20-0.22-0.25-0.24-0.12-0.19-3.20-2.20----420.00-420.00---22.00-10.00-5.60-
EPS Actual-30255.90-11182.53-7517.37-58058.26-9216.0013330.56-5857.88-3405.52-6686.23-2389.21-3639.00-1162.50-1641.21-1218.93-9690.98-1381.92-1811.84-1406.98-893.50-970.31-1309.33-23.26-0.01-46.07-4698.74-0.01-35.85-105.20-111.59-0.18-0.17-7.20-9.50-5.00-3.40-4.800.20-4.60-4.60-0.21-0.23-3.06-0.70-604.70-895.63-604.26-1084.80-1084.80-8.07-0.77--3.380.35-
Surprise----------------------------------1900.00%-1689.47%-2300.00%192.29%-1740.00%-1816.67%-75.00%-21.05%4.38%68.18%----158.29%-158.29%---66.20%106.25%-
Timing-----------------------------------------------Pre-market---Pre-marketAfter-hours-

Key Statistics & Ratios

Market Cap2.37M
Enterprise Value3.10M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.31
Price / Book0.16
EPS357.88
Book Value7.01
Revenue (TTM)7.53M
Gross Profit (TTM)2.66M
EBITDA-5.37M
Profit Margin-92.30%
Operating Margin-59.28%
Return on Equity-72.70%
Return on Assets-16.41%
Shares Outstanding2.51M
Shares Float2.51M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Hold
Based on 1 analystsTarget 20.00
  • Hold
    1

Ownership Breakdown

Institutions
16.89%
Insiders
0.90%
Retail / Other
82.21%

Top Institutional Holders

  • Mariner Wealth Advisors LLC
    100.00K2.17%
  • Armistice Capital, LLC
    71.87K1.56%
  • Geode Capital Management, LLC
    16.85K0.37%
  • UBS Group AG
    3.32K0.07%
  • Citigroup Inc
    150.00%
  • Integrated Wealth Concepts LLC
    80.00%
  • SBI Securities Co Ltd
    30.00%
  • Danske Bank A/S.
    10.00%
  • ADAR1 Capital Management LLC
    00.00%
  • Tower Research Capital LLC
    00.00%
  • Bank of America Corp
    00.00%
  • Citadel Advisors Llc
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    9.30K0.20%

Stock Splits

  • Oct 30, 20261:4
  • Mar 27, 20261:5
  • Nov 28, 20251:8
  • Jul 21, 20251:3
  • Mar 18, 20251:12
  • Jul 28, 20231:20